REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
9.40
+0.36 (3.98%)
Apr 14, 2026, 12:29 PM EDT - Market open
REGENXBIO Market Cap
REGENXBIO has a market cap or net worth of $485.2 million as of April 14, 2026. Its market cap has increased by 18.14% in one year.
Market Cap
485.20M
Enterprise Value
486.28M
1-Year Change
18.14%
Ranking
Category
Stock Price
$9.40
Market Cap Chart
Since September 17, 2015, REGENXBIO's market cap has decreased from $749.30M to $485.20M, a decrease of -35.25%. That is a compound annual growth rate of -4.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 454.20M | -37.70% |
| Dec 31, 2025 | 729.00M | 90.34% |
| Dec 31, 2024 | 383.00M | -51.50% |
| Dec 29, 2023 | 789.70M | -19.57% |
| Dec 30, 2022 | 981.90M | -29.79% |
| Dec 31, 2021 | 1.40B | -17.57% |
| Dec 31, 2020 | 1.70B | 12.32% |
| Dec 31, 2019 | 1.51B | 0.48% |
| Dec 31, 2018 | 1.50B | 45.18% |
| Dec 29, 2017 | 1.04B | 110.87% |
| Dec 30, 2016 | 491.10M | 12.43% |
| Dec 31, 2015 | 436.80M | -41.71% |
| Sep 17, 2015 | 749.30M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ADC Therapeutics | 475.15M |
| Zentalis Pharmaceuticals | 468.85M |
| Verastem | 466.40M |
| Absci | 456.00M |
| vTv Therapeutics | 453.69M |
| Atea Pharmaceuticals | 451.74M |
| Assembly Biosciences | 450.82M |
| Lexeo Therapeutics | 443.04M |